DM Healthcare Investment
Investment Portfolio
RegeNephro. Kyoto, JP: Specialized regenerative medicine company designing renal failure treatments using the Nephron progenitor cells (NPCs).
Humacyte. North Carolina, USA: Bioengineered human tissues which can treat diseases and conditions across a wide range of clinical needs.
Huanova. Shenzhen, CN: Medical devices company producing high-quality hydrogel products used for a variety of purposes ranging from hemostasis to dental repair.
Iviva Medical. Boston, USA: A leading regenerative medicine company focused on solutions for late stage kidney failure and diabetes. DMH lead seed round and an interim CB round.
uLab Systems. San Francisco, USA: The leading AI treatment software company for dental applications. Gives dentists greater freedom in designing treatment plans.
Asia Regenerative Medicine (ARM). Shenzhen, CN: Forerunner in regenerative medicine research and commercialization in Asia. The organization combines talented minds from various medical fields with a seasoned team of financial experts to create artificial organs such as the pancreas, the kidney, the lung and other organs.
Asia Kidney Rebuilding. Guangzhou, CN: Engaged in renal cell production, dialysis modules, and artificial kidney scaffold development.
Broncus Medical. San Jose, USA: Broncus, a pioneer in the field of Interventional Pulmonology, is a medical device company specializing in the global development and distribution of innovative lung solutions. Broncus' integrated whole lung access navigation platform addresses the clinical challenges and unmet needs of existing technologies in the diagnosis and treatment of lung disease.
Convergence Biomanufacturing Ltd. (ConvBio) Shenzhen, CN: Manipulating cells and other particles using acoustic field forces and assembling high fidelity tissues and organ mimics. ConvBio produces and markets Acoustic Assemblers, consumables, and provides tissue assembly and drug discovery services.
Riton Biomanufacturing Co., Ltd. Guangzhou, CN: Leading lingual-side orthodontic braces and 3D printer producer in the Chinese dental market.
China Biotech Services Holdings Ltd. (08037.HK): Regional leader in dental supply and healthcare products.
Angel Align (6699.HK): The leading Chinese Invisalign company, having more than 50% market share in China. DMH lead round A investment and Lixin served as chairman between 2007 - 2009.
Wego Medical (01066.HK): The largest medical consumables producer in China, DMH helped upgrading it from a low-end volume producer to a more advanced technology driven company.
Sigilon Therapeutics. Massachusetts, USA: Sigilon Therapeutics seeks to develop functional cures for patients with a broad range of acute and chronic diseases by harnessing the power of the human cell through its Shielded Living Therapeutics™ platform.
Miromatrix Medical. Minnesota, USA: Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. Miromatrix Medical's initial development focus is on human livers and kidneys.
Rain Biotech Solutions Limited. Shatin, Hong Kong SAR: A leading cell sorting and imaging equipment company driven by AI technology. Supported by Professor Chia-Hung Chen's lab in Hong Kong City University and Hong Kong government Innovation and Technology Fund (ITF).
Asia Pharma Tech. Guangzhou, CN: Specialized in drug discovery and development using organ, cell, organoid, and high fidelty organ mimics. Mainly focusing on kidney, liver, lung, as well as heart and neural system regeneration and therapies.
